Clinical Trial Update: Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of infusions of iNKT cells and CD8+ T cells in patients with advanced solid tumors, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• CD8+ T cell infusion (CD8+ T cells)
• iNKT cell infusion (iNKT cells)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Non-small Cell Lung Cancer, Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING